7-[2-(环丙基甲氧基)-6-羟基苯基]-1,4-二氢-5-(3S)-3-哌啶基-2H-吡啶并[2,3-d][1,3]恶嗪-2-酮
共找到6条“7-[2-(环丙基甲氧基)-6-羟基苯基]-1,4-二氢-5-(3S)-3-哌啶基-2H-吡啶并[2,3-d][1,3]恶嗪-2-酮”产品
7-[2-(环丙基甲氧基)-6-羟基苯基]-1,4-二氢-5-(3S)-3-哌啶基-2H-吡啶并[2,3-d][1,3]恶嗪-2-酮2H-Pyrido2,3-d1,3oxazin-2-one,7-2-(cyclopropylmethoxy)-6-hydroxyphenyl-1,4-dihydro-5-(3S)-3-piperidinyl-
快速询单 别名：7-[2-(环丙基甲氧基)-6-羟基苯基]-1,4-二氢-5-(3S)-3-哌啶基-2H-吡啶并[2,3-d][1,3]恶嗪-2-酮;7-[2-(环丙基甲氧基)-6-羟基苯基]-1,4-二氢-5-(3s)-3-哌啶基-2H-吡啶并[2,3-d][1,3]噁嗪-2-酮;Bay 65-1942 (游离基) 基本信息
LogP：4.23890 PSA：92.71000 密度：1.286简介
Bay 65-1942 free base 是一种 ATP 竞争性的选择性 IKKβ 抑制剂。 了解化合物详情 
3001005926
![2-Methyl-2-propanyl (3R)-3-(7-{2-(cyclopropylmethoxy)-6-[(4-metho xybenzyl)oxy]phenyl}-2-oxo-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazi n-5-yl)-1-piperidinecarboxylate结构式](http://hg.y866.cn/compound/lib/scimg/cas/150/600734-05-2.png "2-Methyl-2-propanyl (3R)-3-(7-{2-(cyclopropylmethoxy)-6-[(4-metho xybenzyl)oxy]phenyl}-2-oxo-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazi n-5-yl)-1-piperidinecarboxylate结构式")
![3-[7-[2-(环丙基甲氧基)-6-[(4-甲氧基苯基)甲氧基]苯基]-1,4-二氢-2-氧代-2H-吡啶并[2,3-D][1,3]恶嗪-5-基]-1-哌啶甲酸叔丁酯结构式](http://hg.y866.cn/compound/lib/scimg/cas/150/406213-01-2.png "3-[7-[2-(环丙基甲氧基)-6-[(4-甲氧基苯基)甲氧基]苯基]-1,4-二氢-2-氧代-2H-吡啶并[2,3-D][1,3]恶嗪-5-基]-1-哌啶甲酸叔丁酯结构式")
![3-[(2-tert-butyl-5-methoxy-1,3-benzothiazol-6-yl)carbamothioylsulfanyl]propanoic acid结构式](http://hg.y866.cn/compound/lib/scimg/cas/150/81059-04-3.png "3-[(2-tert-butyl-5-methoxy-1,3-benzothiazol-6-yl)carbamothioylsulfanyl]propanoic acid结构式")
![[(1aS,1bα,5aα,6aβ)-2α-(β-D-Glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-6α-yl]α-D-galactopyranoside结构式](http://hg.y866.cn/compound/lib/scimg/cas/150/81720-06-1.png "[(1aS,1bα,5aα,6aβ)-2α-(β-D-Glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-6α-yl]α-D-galactopyranoside结构式")
